Short interest in Eliem Therapeutics Inc (NASDAQ:ELYM) increased during the last reporting period, rising from 57.19K to 373.28K. This put 0.77% of the company's publicly available shares short.

Short interest for Eliem Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Eliem Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 282.49K shares traded per day, it would take 1.32 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.